Growth Opportunities in Therapeutic Drug Monitoring Market

1. Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023 The Research Report on Therapeutic Drug Monitoring Market, By Considering useful aspects like; Application, Product, End Users- Global Future Forecast till 2023, published by MarketsandMarkets™, the report studies Market Insights and Growth opportunities For the global Therapeutic Drug Monitoring market over the forecast period to 2023. The Therapeutic Drug Monitoring Market is projected to reach USD 1.63 Billion by 2023 at a CAGR of 5.9%. The Therapeutic Drug Monitoring Market has been categorized based on product, class of drugs, technology, end user, and region. On the basis of technology, the therapeutic drug monitoring market is segmented into immunoassay and chromatography & MS. In 2018, the immunoassay segment is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is mainly due to the increasing incidence of chronic and infectious diseases and technological innovation. On the basis of end user, the therapeutic drug monitoring market is divided into hospital laboratories, commercial/private laboratories, and other end users. Hospital laboratories is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories as they have the appropriate equipment as well as skilled staff to deliver clinically meaningful interpretations from TDM assays. In 2018, North America is expected to account for the largest share of the global therapeutic drug monitoring market, while Asia Pacific is expected to grow at the highest rate during the forecast period. The dominant share of the North American market is attributed to its well- established pharmaceutical industry, the presence of leading pharmaceutical and biotechnology companies, favorable government funding, and high R&D investments in this region. 1

2. The Therapeutic Drug Monitoring market is fragmented with the presence of emerging players; The key players operating in the therapeutic drug monitoring market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US)…..Read More Request a Sample Copy of "Therapeutic Drug Monitoring Market" Consist of tables and figures and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=155350443 Therapeutic Drug Monitoring Market by Product, •Consumables •Equipment Therapeutic Drug Monitoring Market, by Technology •Chemiluminescent Immunoassay (CLIA) •Fluorescence Immunoassay (FPIA) 2

3. •Radioimmunoassay (RIA) Therapeutic Drug Monitoring Market, by Class of Drug •Antiepileptic Drugs •Antiarrhythmic Drugs •Immunosuppressant Drugs •Antibiotic Drugs Therapeutic Drug Monitoring Market, by End User •Commercial/Private Labs •Hospital Labs •Other End Users (Academic Institutes and Research Universities) Therapeutic Drug Monitoring Market, by Chromatography & Mass Spectroscopy •Gas Chromatography/Mass Spectrometry (GC-MS) •Liquid Chromatography/Mass Spectrometry (LC-MS) Therapeutic Drug Monitoring Market, by Region; •North America (US, Canada) •Europe (UK, Germany, Others) •Asia •Rest of the World For any queries Speak to our Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=155350443 Major Key Points from Table of Content: •Introduction •Research Methodology •Therapeutic Drug Monitoring Market by Product. •Therapeutic Drug Monitoring Market, by Technology. •Competitive Landscape •Company Profiles 3

4. Objectives of the Study •To define, describe, and forecast the therapeutic drug monitoring market on the basis of technology, product, class of drug, end user, and regions •To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) •To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market •To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players •To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW) Major Key Points from List of Tables: • Therapeutic Drug Monitoring Equipment Market, By Type, 2016–2023 (USD Million) •Therapeutic Drug Monitoring Market for Chromatography and MS Detectors, By Region, 2016–2023 (USD Million) •Therapeutic Drug Monitoring Market, By Technology, 2016–2023 (USD Million) •Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million) •Therapeutic Drug Monitoring Immunoassays Market, By Region, 2016–2023 (USD Million) •North America: Therapeutic Drug Monitoring Market, By Country, 2016–2023 (USD Million) •US: Therapeutic Drug Monitoring Market, By Product, 2016–2023 (USD Million) •Canada: Therapeutic Drug Monitoring Immunoassays Market, By Type, 2016–2023 (USD Million)……. Click To Read Full Toc Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=155350443 Major Key Points from List of Figures: •Therapeutic Drug Monitoring Market, By Product, 2018 vs 2023 (USD Billion) •Therapeutic Drug Monitoring Market, By Technology, 2018 vs 2023 (USD Million) •Geographic Snapshot of the Therapeutic Drug Monitoring Market 4

5. •Therapeutic Drug Monitoring Market: Top-Down Approach •Therapeutic Drug Monitoring Market: Drivers, Restraints, Opportunities, and Challenges •North America: Therapeutic Drug Monitoring Market Snapshot •Abbott Laboratories: Company Snapshot (2017) •Roche Diagnostics: Company Snapshot (2017) About MarketsandMarkets™ - MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact Us: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 5

6. USA: +1-888-600-6441 Email: sales@marketsandmarkets.com 6